People respond very differently to infection with the novel coronavirus (SARS-CoV-2). While some patients develop no symptoms at all, others will develop severe disease and may even die. For this reason, there is an urgent need for ‘biomarkers’, quantifiable biological characteristics which could provide a reliable means of predicting disease progression and severity. A research team led by Prof. Dr. Markus Ralser (Director of Charité’s Institute of Biochemistry, holder of an Einstein Professorship and Group Leader at the Francis Crick Institute) used state-of-the-art analytical techniques to rapidly determine the levels of various proteins in the blood plasma. This approach enabled the researchers to identify various protein biomarkers in the blood plasma of patients with COVID-19 which were linked to the severity of their disease.
Could the blood of COVID-19 patients ... - Lung Conditions C...
Could the blood of COVID-19 patients be used to predict disease progression?
Written by
2greys
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Study finds over 80 percent of COVID-19 patients have vitamin D deficiency.
prevalent in men.
Over 80 percent of 200 COVID-19 patients in a hospital in Spain have vitamin D...
Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults.
National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of...
Six distinct 'types' of COVID-19 identified.
found that these types differed in the severity of the disease and the need for respiratory support...
Covid 19 Spring Booster (4th jab)
do you think I could be long covid
Asthma advice/sharing your symptoms/peace of mind please. 
Re earlier post on different forum.
A sobering experience- and an update to an earlier post
